Indication · Neurology & Neurosurgery
Spinal cord injury and paralysis
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
110
Cleared or approved since 2000
PMA and De Novo
7
Higher-risk or first-of-kind devices
Breakthrough devices
2
Authorized through June 30, 2026
Recruiting device trials
278
1,568 device trials in all
Breakthrough-designated devices
- ARC-EX SystemOnward Medical, Inc. · 2025
1 more devices with a free account
Devices
110 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- ARC-EX System
Onward Medical, Inc. · De Novo · Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation · newest 2025 · 2 decisions
59 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
Kessler FoundationAcademic, hospital or other
NCT06643312 · 50 participants (planned) · Start Oct 22, 2024 · Primary completion Oct 2029
Device: The Tethered Pelvic Assist Device (TPAD) · For: SCI - Spinal Cord Injury
Sites: West Orange, New Jersey
1,567 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Stimulator, Neuromuscular, External Functional (GZI)45
- Wheelchair, Standup (IPL)33
- Powered Exoskeleton (PHL)19
- Tong, Skull For Traction (HAX)5
- Transcutaneous Electrical Spine Stimulator To Improve Skeletal Muscle Strength And Sensation (SDO)3
- Stimulator, Neuromuscular, Implanted (GZC)2
- Implanted Diaphragmatic/Phrenic Nerve Stimulator (GZE)2
- Diaphragmatic/Phrenic Nerve Laparoscopically-Implanted Stimulator (OIR)1
Research
- Device studies on spinal cord injury across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.